Mismatch repair deficiency is rare in bone and soft tissue tumors-Reference-Cited by-同舟云学术

Mismatch repair deficiency is rare in bone and soft tissue tumors

Published:2021-06-08 Issue:4 Volume:79 Page:509-520
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Lam Suk Wai¹^ORCID,Kostine Marie²^ORCID,Miranda Noel F C C¹^ORCID,Schöffski Patrick³⁴^ORCID,Lee Che‐Jui³⁴^ORCID,Morreau Hans¹,Bovée Judith V M G¹^ORCID

Affiliation:

1. Department of Pathology Leiden University Medical Center Leiden The Netherlands

2. Department of Rheumatology Centre Hospitalier Universitaire de Bordeaux Groupe hospitalier Pellegrin Bordeaux France

3. Department of General Medical Oncology University Hospitals Leuven Leuven Cancer Institute LeuvenBelgium

4. Department of Oncology KU Leuven Laboratory of Experimental Oncology Leuven Belgium

Funder

Leids Universitair Medisch Centrum

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.14377

Reference57 articles.

1. The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

2. Immune checkpoint inhibitors: recent progress and potential biomarkers

3. Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment

4. Correlating programmed death ligand 1 (PD-L1) expression, mismatch repair deficiency, and outcomes across tumor types: implications for immunotherapy

5. Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA mismatch repair deficiency as a biomarker in sarcoma;Surgical Oncology Insight;2024-12

2. Soft Tissue Fine-Needle Aspiration;Surgical Pathology Clinics;2024-09

3. Immunotherapy in Sarcoma: Current Data and Promising Strategies;American Society of Clinical Oncology Educational Book;2024-06

4. Novel biomarkers in bone sarcomas — diagnosis, treatment selection, and clinical trials;Oncology in Clinical Practice;2024-04-19

5. When Vessels and Sarcomas Combine: A Review of the Inferior Vena Cava Leiomyosarcoma;Journal of Vascular Diseases;2024-01-08